Skip to main content
SpringerLink
Log in

Incidence and Treatment of Local Site Recurrences Following RFA of Colorectal Liver Metastases

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

Patients with colorectal liver metastases (CRLM) who are ineligible for curative surgery are potential candidates for radiofrequency ablation (RFA). Although RFA has emerged as a well accepted and documented treatment modality, there are still some reservations because of initially high rates of local site recurrences (LSR). The aim of the present study was to evaluate LSR levels following RFA treatment, with a specific focus on re-treatment and survival.

Patients and methods

All patients ineligible for curative resection of CRLM and undergoing RFA alone or in combination with resection were prospectively included from July 2000 to December 2010 and retrospectively analyzed. Patients with untreatable extrahepatic disease were excluded. FDG PET–CT was conducted at 3–6 month intervals after RFA. Patients with LSR were evaluated for re-treatment.

Results

A total of 132 patients were treated with RFA, which was combined with resection in 64 patients. A total of 290 lesions were ablated, with a mean number of 2.19 per patient and a mean size of 2.2 cm. Median survival was 41 months, with a 3- and 5-year survival of, respectively, 60 and 30.8 %. Following initial RFA, 39 patients developed an LSR in 40 ablated lesions, and local recurrence was strongly related to lesion size. Re-treatment could be performed in 26/39 patients, of whom eight remained disease-free.

Conclusions

Radiofrequency ablation can be applied to CRLM of less than 3 cm with curative intent. In the absence of extensive intrahepatic or extrahepatic disease, renewed treatment of local recurrences should be considered and is often successful.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Leporrier J, Maurel J, Chiche L et al (2006) A population-based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer. Br J Surg 93:465–474

    Article  PubMed  CAS  Google Scholar 

  2. Koopman M, Antonini NF, Douma J et al (2007) Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial. Lancet 370(9582):135–142

    Article  PubMed  CAS  Google Scholar 

  3. Seymour MT, Maughan TS, Ledermann JA et al (2007) Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial. Lancet 370(9582):143–152

    Article  PubMed  CAS  Google Scholar 

  4. Abdalla EK, Vauthey JN, Ellis LM et al (2004) Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239(6):818–825

    Article  PubMed  Google Scholar 

  5. Fernandez FG, Drebin JA, Linehan DC et al (2004) Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg 240:438–447

    Article  PubMed  Google Scholar 

  6. Smith MD, McCall JL (2009) Systematic review of tumour number and outcome after radical treatment of colorectal liver metastases. Br J Surg 96:1101–1113

    Article  PubMed  CAS  Google Scholar 

  7. Wei AC, Greig PD, Grant D et al (2006) Survival after hepatic resection for colorectal metastases: a 10-year experience. Ann Surg Oncol 13:668–676

    Article  PubMed  Google Scholar 

  8. Adam R, Avisar E, Ariche A et al (2001) Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol 8:347–353

    Article  PubMed  CAS  Google Scholar 

  9. Blokhuis TJ, van der Schaaf MC, van den Tol MP et al (2004) Results of radio frequency ablation of primary and secondary liver tumors: long-term follow-up with computed tomography and positron emission tomography-18F-deoxyfluoroglucose scanning. Scand J Gastroenterol 241(Suppl):93–97

    Article  Google Scholar 

  10. Iannitti DA, Dupuy DE, Mayo-Smith WW et al (2002) Hepatic radiofrequency ablation. Arch Surg 137:422–426

    Article  PubMed  Google Scholar 

  11. Wong SL, Mangu PB, Choti MA et al (2010) American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer. J Clin Oncol 28:493–508

    Article  PubMed  Google Scholar 

  12. Kong WT, Zhang WW, Qiu YD et al (2009) Major complications after radiofrequency ablation for liver tumors: analysis of 255 patients. World J Gastroenterol 15:2651–2656

    Article  PubMed  Google Scholar 

  13. Berber E, Tsinberg M, Tellioglu G et al (2008) Resection versus laparoscopic radiofrequency thermal ablation of solitary colorectal liver metastasis. J Gastrointest Surg 12:1967–1972

    Article  PubMed  Google Scholar 

  14. Hammill CW, Billingsley KG, Cassera MA et al (2011) Outcome after laparoscopic radiofrequency ablation of technically resectable colorectal liver metastases. Ann Surg Oncol 18:1947–1954

    Article  PubMed  Google Scholar 

  15. Siperstein AE, Berber E, Ballem N et al (2007) Survival after radiofrequency ablation of colorectal liver metastases: 10-year experience. Ann Surg 246:559–565

    Article  PubMed  Google Scholar 

  16. Van Tilborg AAJM, Meijerink MR, Sietses C et al (2011) Long-term results of radiofrequency ablation for unresectable colorectal liver metastases: a potentially curative intervention. Br J Radiol 84(1002):556–565

    Article  PubMed  Google Scholar 

  17. Wu YZ, Li B, Wang T et al (2011) Radiofrequency ablation vs hepatic resection for solitary colorectal liver metastasis: a meta-analysis. World J Gastroenterol 17:4143–4148

    Article  PubMed  Google Scholar 

  18. Evrard S, Rivoire M, Arnaud J-P, Lermite E et al (2012) Unresectable colorectal cancer liver metastases treated by intraoperative radiofrequency ablation with or without resection. Br J Surg 99:558–565

    Article  PubMed  CAS  Google Scholar 

  19. Jiao LR, Hansen PD, Havlik R et al (1999) Clinical short-term results of radiofrequency ablation in primary and secondary liver tumors. Am J Surg 177:303–306

    Article  PubMed  CAS  Google Scholar 

  20. van Duijnhoven FH, Jansen MC, Junggeburt JMC et al (2006) Factors influencing the local failure rate of radiofrequency ablation of colorectal liver metastases. Ann Surg Oncol 13:651–658

    Article  PubMed  Google Scholar 

  21. Scaife C, Curley SA (2003) Complication, local recurrence, and survival rates after radiofrequency ablation for hepatic malignancies. Surg Oncol Clin N Am 12:243–255

    Article  PubMed  Google Scholar 

  22. Solbiati L, Livraghi T, Goldberg SN et al (2001) Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 221:159–166

    Article  PubMed  CAS  Google Scholar 

  23. White TJ, Roy-Choudhury SH, Breen DJ et al (2004) Percutaneous radiofrequency ablation of colorectal hepatic metastases—initial experience. An adjunct technique to systemic chemotherapy for those with inoperable colorectal hepatic metastases. Dig Surg 21:314–320

    Article  PubMed  CAS  Google Scholar 

  24. Goldberg SN, Grassi CJ, Cardella JF et al (2005) Image-guided tumor ablation: standardization of terminology and reporting criteria. J Vasc Intervent Radiol 16:765–778

    Article  Google Scholar 

  25. Ayav A, Germain A, Marchal F et al (2010) Radiofrequency ablation of unresectable liver tumors: factors associated with incomplete ablation or local recurrence. Am J Surg 200:435–439

    Article  PubMed  Google Scholar 

  26. Sietses C, Meijerink MR, Meijer S et al (2010) The impact of intraoperative ultrasonography on the surgical treatment of patients with colorectal liver metastases. Surg Endosc 24:1917–1922

    Article  PubMed  CAS  Google Scholar 

  27. Meijerink MR, van den Tol P, van Tilborg AAJM et al (2011) Radiofrequency ablation of large size liver tumours using novel plan-parallel expandable bipolar electrodes: initial clinical experience. Eur J Radiol 77:167–171

    Article  PubMed  Google Scholar 

  28. Kunzli BM, Abitabile P, Maurer CA (2011) Radiofrequency ablation of liver tumors: actual limitations and potential solutions in the future. World J Hepatol 3:8–14

    PubMed  Google Scholar 

  29. Kuvshinoff BW, Ota DM (2002) Radiofrequency ablation of liver tumors: influence of technique and tumor size. Surgery 132:605–611

    Article  PubMed  Google Scholar 

  30. Mulier S, Ruers T, Jamart J et al (2008) Radiofrequency ablation versus resection for resectable colorectal liver metastases: time for a randomized trial? An update. Dig Surg 25:445–460

    Article  PubMed  Google Scholar 

  31. de Jong MC, Mayo SC, Pulitano C et al (2009) Repeat curative intent liver surgery is safe and effective for recurrent colorectal liver metastasis: results from an international multi-institutional analysis. J Gastrointest Surg 13:2141–2151

    Article  PubMed  Google Scholar 

  32. Fong Y, Fortner J, Sun RL et al (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230:309–318

    Article  PubMed  CAS  Google Scholar 

  33. Martin R, Paty P, Fong Y et al (2003) Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis. J Am Coll Surg 197:233–241

    Article  PubMed  Google Scholar 

  34. Mayo SC, Shore AD, Nathan H et al (2011) Refining the definition of perioperative mortality following hepatectomy using death within 90 days as the standard criterion. HPB (Oxford) 13:473–482

    Article  Google Scholar 

  35. Weber SM, Jarnagin WR, DeMatteo RP et al (2000) Survival after resection of multiple hepatic colorectal metastases. Ann Surg Oncol 7:643–650

    Article  PubMed  CAS  Google Scholar 

  36. Kokudo N, Imamura H, Sugawara Y et al (2004) Surgery for multiple hepatic colorectal metastases. J Hepatobiliary Pancreat Surg 11:84–91

    Article  PubMed  Google Scholar 

  37. Muratore A, Ribero D, Zimmitti G et al (2010) Resection margin and recurrence-free survival after liver resection of colorectal metastases. Ann Surg Oncol 17:1324–1329

    Article  PubMed  Google Scholar 

  38. Tanaka K, Shimada H, Fujii Y et al (2004) Pre-hepatectomy prognostic staging to determine treatment strategy for colorectal cancer metastases to the liver. Langenbecks Arch Surg 389:371–379

    Article  PubMed  Google Scholar 

  39. Jones N, McNally M, Malhotra L et al (2012) Repeat hepatectomy for metastatic colorectal cancer is safe but marginally effective. Ann Surg Oncol 19:2224–2229

    Article  PubMed  Google Scholar 

  40. Berber E, Siperstein AE (2007) Perioperative outcome after laparoscopic radiofrequency ablation of liver tumors: an analysis of 521 cases. Surg Endosc 21:613–618

    Article  PubMed  CAS  Google Scholar 

  41. Reuter NP, Woodall CE, Scoggins CR et al (2009) Radiofrequency ablation vs. resection for hepatic colorectal metastasis: therapeutically equivalent? J Gastrointest Surg 13:486–491

    Article  PubMed  Google Scholar 

  42. Langenhoff BS, Oyen WJG, Jager GJ et al (2002) Efficacy of fluorine-18-deoxyglucose positron emission tomography in detecting tumor recurrence after local ablative therapy for liver metastases: a prospective study. J Clin Oncol 20:4453–4458

    Article  PubMed  CAS  Google Scholar 

  43. Sobhani I, Tiret E, Lebtahi R et al (2008) Early detection of recurrence by 18FDG-PET in the follow-up of patients with colorectal cancer. Br J Cancer 98:875–880

    Article  PubMed  CAS  Google Scholar 

  44. Wiering B, Krabbe PFM, Jager GJ et al (2005) The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases. Cancer 104:2658–2670

    Article  PubMed  Google Scholar 

  45. Veit P, Antoch G, Stergar H et al (2006) Detection of residual tumor after radiofrequency ablation of liver metastasis with dual-modality PET/CT: initial results. Eur Radiol 16:80–87

    Article  PubMed  Google Scholar 

  46. Iannitti DA, Martin RCG, Simon CJ et al (2007) Hepatic tumor ablation with clustered microwave antennae: the US Phase II trial. HPB (Oxford) 9:120–124

    Article  Google Scholar 

  47. Simon CJ, Dupuy DE, Mayo-Smith WW (2005) Microwave ablation: principles and applications. Radiographics 25(Suppl):1S69–S83

    Google Scholar 

  48. Jones C, Badger SA, Ellis G (2011) The role of microwave ablation in the management of hepatic colorectal metastases. Surgeon 9:33–37

    Article  PubMed  CAS  Google Scholar 

  49. Lo SS, Fakiris AJ, Chang EL et al (2010) Stereotactic body radiation therapy: a novel treatment modality. Nat Rev Clin Oncol 7:44–54

    Article  PubMed  Google Scholar 

  50. van der Pool AEM, Mendez Romero A, Wunderink W et al (2010) Stereotactic body radiation therapy for colorectal liver metastases. Br J Surg 97:377–382

    Article  PubMed  Google Scholar 

  51. Thomson KR, Cheung W, Ellis SJ et al (2011) Investigation of the safety of irreversible electroporation in humans. J Vasc Interv Radiol 22:611–621

    Article  PubMed  Google Scholar 

  52. Charpentier KP, Wolf F, Noble L et al (2011) Irreversible electroporation of the liver and liver hilum in swine. HPB (Oxf) 13:168–173

    Google Scholar 

  53. Bonomo G, Della Vigna P, Monfardini L et al (2012) Combined therapies for the treatment of technically unresectable liver malignancies: bland embolization and radiofrequency thermal ablation within the same session. Cardiovasc Intervent Radiol 35:1372–1379

    Article  PubMed  Google Scholar 

  54. Hong K, McBride JD, Georgiades CS et al (2009) Salvage therapy for liver-dominant colorectal metastatic adenocarcinoma: comparison between transcatheter arterial chemoembolization versus yttrium-90 radioembolization. J Vasc Intervent Radiol 20:360–367

    Article  Google Scholar 

  55. Nace GW, Steel JL, Amesur N et al (2011) Yttrium-90 radioembolization for colorectal cancer liver metastases: a single institution experience. Int J Surg Oncol 20:1157–1261

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, VUmc Medical Centre, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands

    Karin Nielsen, Matessa O. Macintosh, Babs M. Zonderhuis, Sybren Meijer & M. Petrousjka van den Tol

  2. Department of Radiology, VUmc Medical Centre, Amsterdam, The Netherlands

    Aukje A. J. M. van Tilborg & Martijn R. Meijerink

  3. Department of Nuclear Medicine, VUmc Medical Centre, Amsterdam, The Netherlands

    Emile F. I. Comans

  4. Department of Epidemiology and Biostatistics, VUmc Medical Centre, Amsterdam, The Netherlands

    Elly S. M. de Lange

Authors
  1. Karin Nielsen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Aukje A. J. M. van Tilborg
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Martijn R. Meijerink
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Matessa O. Macintosh
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Babs M. Zonderhuis
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Elly S. M. de Lange
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Emile F. I. Comans
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Sybren Meijer
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. M. Petrousjka van den Tol
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Petrousjka van den Tol.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nielsen, K., van Tilborg, A.A.J.M., Meijerink, M.R. et al. Incidence and Treatment of Local Site Recurrences Following RFA of Colorectal Liver Metastases. World J Surg 37, 1340–1347 (2013). https://doi.org/10.1007/s00268-013-1997-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-013-1997-6

Keywords

Search

Navigation